Company Profile

Nemucore Medical Innovations Inc (AKA: NMI)
Profile last edited on: 6/17/21      CAGE: 56X92      UEI: XJFVQ8JVRED5

Business Identifier: Life-saving nanomedicines for treatment of drug resistant cancers
Year Founded
2008
First Award
2010
Latest Award
2015
Program Status
Inactive
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

One Hollis Street Suite 232
Wellesley, MA 02482
   (617) 943-9983
   info@nemucore.com
   www.nemucore.com
Location: Single
Congr. District: 04
County: Norfolk

Public Profile

Nemucore Medical Innovations Inc is organized around improvement of patient care by developing safe, effective molecularly targeted therapies: life-saving nanomedicines for the treatment of MDR cancers. Targeting multi-drug resistant cancers with a special emphasis on highly lethal women’s cancers, the fim has a commitment to partnering with biopharmaceutical industry to apply proprietary nanoformulation products to drugs that need solutions to difficult delivery problems. By working to know every patient the firm treats, and engaging patient advocacy groups in constructive ways to enhance patient quality of life, Nemucore is dedicated to forwarding knowledge of molecularly targeted therapies to become a leader in the development of revolutionary life saving products for improving cancer patient car

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
5-9
Revenue Range
.5M-1M
VC funded?
Yes
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects

Key People / Management

  Timothy P Coleman -- President and CEO

  Barbara Davis -- CSO

  Michael Masterson -- Founder and Executive Chairman

  William S White -- COO

Company News

There are no news available.